Episode 72 | Jon Bergsteinsson: Founder and Vice President of Global Business Development at Smart-Trial | The Importance of Clinical Strategy in the Early Phases of a Medtech Startup Company episode artwork

EPISODE · Dec 6, 2021 · 42 MIN

Episode 72 | Jon Bergsteinsson: Founder and Vice President of Global Business Development at Smart-Trial | The Importance of Clinical Strategy in the Early Phases of a Medtech Startup Company

from Project Medtech · host Project Medtech

In this episode, Jon and Duane discuss the issue of clinical data collection in medical device development, the lack of clinical data for products on the market, the need for balance between innovation and safety, why you need to think about clinical data early, why sales and marketing need to have a heavy influence in your clinical data collection, how the MDR is affecting innovation in Europe and more. Jon Bergsteinsson LinkedIn Smart-Trial Website Duane Mancini LinkedIn Project Medtech LinkedIn Project Medtech Websiste

Episode metadata supplied by the publisher feed · Published Dec 6, 2021

Embed this episode

Ready to play

Episode 72 | Jon Bergsteinsson: Founder and Vice President of Global Business Development at Smart-Trial | The Importance of Clinical Strategy in the Early Phases of a Medtech Startup Company

0:00 42:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 42 minutes long.

When was this Project Medtech episode published?

This episode was published on December 6, 2021.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!